Company intelligence / Profile preview

CBC Corporation

Chuo-ku, Tokyo, Japan

Ownership: Private
Employees: ~2500
Development stage: Other

Overview

CBC Co., Ltd. is a global Japanese trading and manufacturing company with a significant presence in the pharmaceutical and chemical industries. Through its Chemical & Pharma division and subsidiaries like Procos S.p.A., the company provides active pharmaceutical ingredients (APIs), intermediates, and drug discovery support services. CBC operates as a critical bridge in the global supply chain, offering sourcing, logistics, and contract manufacturing capabilities to pharmaceutical companies worldwide. The company also provides specialized services in custom synthesis and formulation development, supporting both generic and innovative drug programs.

Modalities: Small molecule
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on CBC Corporation.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CBC Corporation.

Explore the full profile